Valinor
6 known investors
Valinor Discovery generates patient-derived datasets combining multi-omics and clinical data to enable machine learning applications in drug development. The company collects longitudinal data across molecular and imaging assays to create virtual patient profiles for pharmaceutical research.
Investors · 6
Campus Founders FundSalt Lake City · $10K – $50K
Mythos Ventures Management, LlcSeattle · $100K – $2M
Castle Island Venturesreported · 2 sourcesBoston · $100K – $5M
Maven 11reportedAmsterdam
Also in the syndicate · 2
SusquehannaTeraWulf
Funding
SEC filings, press & company announcements$25M disclosed across 1 round · 2026
- $25MSeedMar 2026 · 4 sources
Castle Island Ventures (lead), Maven 11, Susquehanna, TeraWulf
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 1
by search overlapCompanies competing with Valinor for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Valinor do?
- Valinor Discovery generates patient-derived datasets combining multi-omics and clinical data to enable machine learning applications in drug development. The company collects longitudinal data across molecular and imaging assays to create virtual patient profiles for pharmaceutical research.
- Who are Valinor's investors?
- Valinor's investors include Campus Founders Fund, Mythos Ventures Management, Llc, Castle Island Ventures, Maven 11.
- How much funding has Valinor raised?
- Valinor has disclosed $25M raised across 1 round.